The sales of antiarrhythmic medicine in Spain are projected to increase steadily from 2024 to 2028. In 2023, the market size stood at 38.3 million USD PPP. The year-on-year growth shows a marginal increase of approximately 0.5% annually over the next five years. From 2024 to 2025, sales increased by 0.52%, from 2025 to 2026 by 0.52%, from 2026 to 2027 by 0.51%, and from 2027 to 2028 by 0.51%. The compound annual growth rate (CAGR) for this period is 0.51%.

Future trends to watch for:

Increasing prevalence of cardiovascular diseases driving the demand for antiarrhythmic medicines.
Technological advancements and new drug developments improving efficacy and patient adherence.
Potential impact of healthcare policies and economic factors on drug pricing and accessibility.